Segmental vitiligo following nine‐valent human papillomavirus vaccination: A case report
Human papillomavirus (HPV) vaccines have significantly reduced the burden of HPV-related malignancies, with the nine‑valent vaccine demonstrating an excellent safety profile. We report a rare case of segmental vitiligo in a 22‑year‑old woman following the standard three‑dose regimen. The patient dev...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2541498 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|